Establishment Labs Holdings (ESTA) Gains from Investment Securities (2017 - 2026)
Establishment Labs Holdings (ESTA) recorded quarterly Gains from Investment Securities of -$47000.0 in Q1 2026, up 95.09% quarter-over-quarter from -$957000.0 in Q4 2025, and down 159.49% on a YoY basis from $79000.0 in Q1 2025.
Establishment Labs Holdings (ESTA) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Gains from Investment Securities history runs 10 years deep, the most recent figure standing at -$47000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 159.49% year-over-year to -$47000.0; the TTM figure through Mar 2026 stood at -$580000.0 (down 202.11% YoY), while the FY2025 annual figure was -$454000.0, down 194.0% from the prior year.
- Gains from Investment Securities was -$47000.0 for Q1 2026 at Establishment Labs Holdings, up from -$957000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.4 million in Q4 2023 to a low of -$1.2 million in Q3 2023.
- Historically, Gains from Investment Securities has averaged $112823.5 across 5 years, with a median of $7000.0 in 2022.
- Biggest YoY gain for Gains from Investment Securities was 11242.86% in 2023; the steepest drop was 24900.0% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at -$234000.0 in 2022, then surged by 1128.63% to $2.4 million in 2023, then slumped by 96.3% to $89000.0 in 2024, then sank by 1175.28% to -$957000.0 in 2025, then soared by 95.09% to -$47000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$47000.0 (Q1 2026), -$957000.0 (Q4 2025), and $77000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.54 Bn | 2.47 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47,000.00 |
| Mar 31, 2026 | -47,000.00 |
| Dec 31, 2025 | -957,000.00 |
| Dec 31, 2025 | -957,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 347,000.00 |
| Jun 30, 2025 | 347,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | -352,000.00 |
| Sep 30, 2024 | -352,000.00 |
| Jun 30, 2024 | 752,000.00 |
| Jun 30, 2024 | 752,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 2.41 Mn |
| Dec 31, 2023 | 2.41 Mn |